Header Logo

Connection

Lynette Rogers to Infant, Newborn

This is a "connection" page, showing publications Lynette Rogers has written about Infant, Newborn.
Connection Strength

1.287
  1. MiR-29b is associated with perinatal inflammation in extremely preterm infants. Pediatr Res. 2021 03; 89(4):889-893.
    View in: PubMed
    Score: 0.133
  2. A Randomized Trial of Maternal Docosahexaenoic Acid Supplementation to Reduce Inflammation in Extremely Preterm Infants. J Pediatr Gastroenterol Nutr. 2019 09; 69(3):388-392.
    View in: PubMed
    Score: 0.127
  3. Alterations in VASP phosphorylation and profilin1 and cofilin1 expression in hyperoxic lung injury and BPD. Respir Res. 2018 Nov 21; 19(1):229.
    View in: PubMed
    Score: 0.120
  4. miR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2017 08 01; 313(2):L339-L349.
    View in: PubMed
    Score: 0.108
  5. Attenuation of miR-17~92 Cluster in Bronchopulmonary Dysplasia. Ann Am Thorac Soc. 2015 Oct; 12(10):1506-13.
    View in: PubMed
    Score: 0.096
  6. Associations between maternal and infant morbidities and sRAGE within the first week of life in extremely preterm infants. PLoS One. 2013; 8(12):e82537.
    View in: PubMed
    Score: 0.085
  7. Plasma lipid metabolites are associated with gestational age but not bronchopulmonary dysplasia. Acta Paediatr. 2012 Aug; 101(8):e321-6.
    View in: PubMed
    Score: 0.076
  8. Maternal inflammation, growth retardation, and preterm birth: insights into adult cardiovascular disease. Life Sci. 2011 Sep 26; 89(13-14):417-21.
    View in: PubMed
    Score: 0.072
  9. Alterations of the thioredoxin system by hyperoxia: implications for alveolar development. Am J Respir Cell Mol Biol. 2009 Nov; 41(5):612-9.
    View in: PubMed
    Score: 0.061
  10. DHA Supplementation Attenuates Inflammation-Associated Gene Expression in the Mammary Gland of Lactating Mothers Who Deliver Preterm. J Nutr. 2022 06 09; 152(6):1404-1414.
    View in: PubMed
    Score: 0.038
  11. Effects of Omega-3-6-9 fatty acid supplementation on behavior and sleep in preterm toddlers with autism symptomatology: Secondary analysis of a randomized clinical trial. Early Hum Dev. 2022 06; 169:105588.
    View in: PubMed
    Score: 0.038
  12. Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates. Pediatr Pulmonol. 2021 12; 56(12):3847-3856.
    View in: PubMed
    Score: 0.036
  13. Docosahexaenoic and arachidonic acid supplementation at 1?year has mixed effects on development and behaviour at age 2 for preterm children. Acta Paediatr. 2021 07; 110(7):2082-2083.
    View in: PubMed
    Score: 0.035
  14. Supplementing Essential Polyunsaturated Fatty Acids-A Matter of Respecting Fetal Development-Reply. JAMA Pediatr. 2019 05 01; 173(5):500.
    View in: PubMed
    Score: 0.031
  15. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial. JAMA Pediatr. 2018 12 01; 172(12):1126-1134.
    View in: PubMed
    Score: 0.030
  16. Nutrition Support Team Guide to Maternal Diet for the Human-Milk-Fed Infant. Nutr Clin Pract. 2018 Oct; 33(5):687-693.
    View in: PubMed
    Score: 0.029
  17. Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms. J Autism Dev Disord. 2017 Nov; 47(11):3358-3369.
    View in: PubMed
    Score: 0.028
  18. Omega-3 and -6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: A randomized controlled trial. Early Hum Dev. 2017 12; 115:64-70.
    View in: PubMed
    Score: 0.028
  19. Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol. BMC Pregnancy Childbirth. 2017 02 13; 17(1):62.
    View in: PubMed
    Score: 0.027
  20. Of mice and men: correlations between microRNA-17~92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2016 Nov 01; 311(5):L981-L984.
    View in: PubMed
    Score: 0.026
  21. A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia. Acta Paediatr. 2016 Apr; 105(4):e170-5.
    View in: PubMed
    Score: 0.025
  22. Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension. J Pediatr. 2015 Feb; 166(2):230-3.
    View in: PubMed
    Score: 0.023
  23. Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure. J Appl Physiol (1985). 2010 May; 108(5):1347-56.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.